Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...

Although some previous studies have suggested an increased risk of bladder cancer with use of the diabetes drug pioglitazone, analyses that included nearly 200,000 patients found no statistically ...

Drug regulators in Germany and France have ordered doctors to stop prescribing the type 2 diabetes drug pioglitazone (Actos) following a French study suggesting a heightened risk of bladder cancer.

The second circuit court in New York reviewed claims that Japan-based Takeda Pharmaceuticals delayed a competitor from releasing a generic version of Actos, a diabetes drug, Court House News reports.

LOS ANGELES (Reuters) - The U.S. Food and Drug Administration said on Friday its has begun a safety review of diabetes drug Actos after receiving early results from a long-term study designed to ...

THE diabetes drug pioglitazone (Actos) slowed the progression of atherosclerosis and showed other cardiovascular benefits in a recent head-to-head clinical trial against glimepiride (Amaryl). Known as ...

Dusseldorf, Germany - Until new evidence becomes available, the benefit/risk ratio of the diabetes drug pioglitazone (Actos, Takeda Pharmaceuticals) remains unclear, with no definite evidence of ...

CHICAGO (AP) -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it ...

* Better blood sugar lowering, weight loss with exenatide * 66 pct reach A1C target, vs 56 for Actos, 42 for Januvia By Bill Berkrot NEW YORK, June 6 (Reuters) - The high-profile experimental ...

Takeda announced positive late-stage results for its new type 2 diabetes drug, fasiglifam (TAK-875), the first GPR40 agonist to reach late-stage development. Fasiglifam has the potential to be a ...

“[…] the results of this study indicate that pioglitazone might be useful in treating refractory skin ulcers, a typical condition that reduces the quality of life ...